DrugPatentWatch Database Preview

MINOCIN Drug Profile

When do Minocin patents expire, and what generic alternatives are available?

Minocin is a drug marketed by Precision Dermat, Triax Pharms, Lederle, and Rempex Pharms. and is included in five NDAs. There are two patents protecting this drug.

The generic ingredient in MINOCIN is minocycline hydrochloride. There are fourteen drug master file entries for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the minocycline hydrochloride profile page.

Summary for MINOCIN

US Patents:	2
Applicants:	4
NDAs:	5
Suppliers / Packagers:	5
Bulk Api Vendors:	37
Clinical Trials:	34
Patent Applications:	8,689
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for MINOCIN
DailyMed Link:	MINOCIN at DailyMed

Drug patent expirations by year for MINOCIN

Pharmacology for MINOCIN

Ingredient-type	Tetracyclines
Drug Class	Tetracycline-class Drug

Medical Subject Heading (MeSH) Categories for MINOCIN

Anti-Bacterial Agents

Synonyms for MINOCIN

(2E,4S,4aR,5aS,12aR)-2-(amino-hydroxy-methylidene)-4,7-bis(dimethylamino)-10,11,12a-trihydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3 ,12-trione
(2E,4S,4AS,5AR,12AS)-2-[AMINO(HYDROXY)METHYLIDENE]-4,7-BIS(DIMETHYLAMINO)-10,11,12A-TRIHYDROXY-1,2,3,4,4A,5,5A,6,12,12A-DECAHYDROTETRACENE-1,3,12-TRIONE
(2E,4S,4aS,5aR,12aS)-2-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-10,11,12a-trihydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z,4S,4aS,5aR,12aS)-2-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-10,11,12a-trihydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(4S,4aS,5aR,12aS)-2-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-10,11,12a-trihydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE
(4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide
(4S,4aS,5aR,12aS)4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxonaphthacene-2-carboxamide;(4S,4aS,5aR,12aS)4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydro
10118-90-8
1071761-03-9
13614-98-7 (mono-hydrochloride)
1371-EP2269978A2
1371-EP2269985A2
1371-EP2269991A2
1371-EP2272832A1
1371-EP2284150A2
1371-EP2284151A2
1371-EP2284152A2
1371-EP2284153A2
1371-EP2284155A2
1371-EP2284156A2
1371-EP2284164A2
1371-EP2287140A2
1371-EP2287148A2
1371-EP2287150A2
1371-EP2289871A1
1371-EP2292590A2
1371-EP2292612A2
1371-EP2295402A2
1371-EP2295419A2
1371-EP2295426A1
1371-EP2295427A1
1371-EP2298732A1
1371-EP2301534A1
1371-EP2301912A2
1371-EP2301913A1
1371-EP2301914A1
1371-EP2301916A2
1371-EP2305637A2
1371-EP2308832A1
1371-EP2308863A1
1371-EP2311451A1
1371-EP2311796A1
1371-EP2311797A1
1371-EP2311798A1
1371-EP2311799A1
1371-EP2316450A1
146440-73-5
17175-40-5
18M908
2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S-(4alpha,4aalpha,5aalpha,12aalpha))-
2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)-
24058-90-0
4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide
7-Dimethylamino-6-demethyl-6-deoxytetracycline
AB00053501_04
AB00053501_05
AB00053501-03
AC1L2NSN
AC1NQXWM
AC1NSG0A
AJ-65483
AK322058
Akamin
Aknemin
AKOS015969674
Alti-Minocycline
AM20090714
API0003397
Apo-Minocycline
Arestin
BCBcMAP01_000027
BCP9000928
BDBM50103599
Bio-0062
Borymycin
BRN 3077644
BSPBio_002035
C07225
C23H27N3O7
CAS-10118-90-8
CHEBI:50694
CHEMBL1434
CHEMBL259172
CL 59806
CRL-1605 & Minocycline
D05045
D08LTU
DB01017
DivK1c_000450
DSSTox_CID_25033
DSSTox_GSID_45033
DSSTox_RID_80650
DTXSID1045033
DYKFCLLONBREIL-KVUCHLLUSA-N
Dynacin
FT-0628949
FYY3R43WGO
Gen-Minocycline
HMS2090D03
HSDB 3130
IDI1_000450
J-500789
KBio1_000450
KBio2_001447
KBio2_004015
KBio2_006583
KBio3_001535
KBioGR_000583
KBioSS_001447
Klinomycin
KSC-12-231B
KUC106429N
Lactoferrin B & Minocycline
Lactoferrin H & Minocycline
LMPK07000002
LS-93850
MINO
Mino-Tabs
Minociclina
Minociclina [INN-Spanish]
minociclinum
Minocin (Hydrochloride)
Minocin (TN)
Minocline
Minocyclin
minocycline
Minocycline (USAN/INN)
Minocycline [USAN:BAN:INN]
Minocycline [USAN:INN:BAN]
Minocycline Monohydrochloride
Minocyclinum
Minocyclinum [INN-Latin]
Minocyn
Minoderm
Minoz
MIY
MolPort-020-005-814
NCGC00178854-01
NCGC00183044-01
NCGC00188954-01
NINDS_000450
Novo-Minocycline
NSC 141993
NSC141993
PL009220
PL045106
Prestwick0_000315
Prestwick1_000315
Prestwick2_000315
SBI-0051449.P003
SCHEMBL16681149
SCHEMBL24315
SCHEMBL4042
Sebomin
SMP1_000191
Solodyn
SPBio_000974
SPBio_002529
Spectrum_000967
Spectrum2_001047
Spectrum3_000508
Spectrum4_000062
Spectrum5_001293
Tox21_113643
Tri-minocycline
UNII-FYY3R43WGO
Vectrin
Vectrin (Hydrochloride)
ZINC100409820
ZINC14879992
ZINC4019704

US Patents and Regulatory Information for MINOCIN

+ Get email alerts for changes to this table

Glossary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Precision Dermat	MINOCIN	minocycline hydrochloride	CAPSULE;ORAL	050649-001	May 31, 1990	AB	RX	Yes	No	➤ Try a Free Trial	➤ Try a Free Trial				➤ Try a Free Trial
Rempex Pharms	MINOCIN	minocycline hydrochloride	INJECTABLE;INJECTION	050444-001	Approved Prior to Jan 1, 1982		RX	Yes	Yes	➤ Try a Free Trial	➤ Try a Free Trial				➤ Try a Free Trial
Triax Pharms	MINOCIN	minocycline hydrochloride	CAPSULE;ORAL	050315-002	Approved Prior to Jan 1, 1982		DISCN	No	No	➤ Try a Free Trial	➤ Try a Free Trial				➤ Try a Free Trial
Rempex Pharms	MINOCIN	minocycline hydrochloride	INJECTABLE;INJECTION	050444-001	Approved Prior to Jan 1, 1982		RX	Yes	Yes	➤ Try a Free Trial	➤ Try a Free Trial				➤ Try a Free Trial
Precision Dermat	MINOCIN	minocycline hydrochloride	CAPSULE;ORAL	050649-003	Feb 12, 2001		DISCN	Yes	No	➤ Try a Free Trial	➤ Try a Free Trial				➤ Try a Free Trial
Precision Dermat	MINOCIN	minocycline hydrochloride	CAPSULE;ORAL	050649-002	May 31, 1990	AB	RX	Yes	No	➤ Try a Free Trial	➤ Try a Free Trial				➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

International Patents for MINOCIN

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Country	Document Number	Estimated Expiration
Japan	2016145253	➤ Try a Free Trial
Singapore	185513	➤ Try a Free Trial
Japan	6290298	➤ Try a Free Trial
China	102970992	➤ Try a Free Trial
Australia	2011252919	➤ Try a Free Trial
World Intellectual Property Organization (WIPO)	2011143503	➤ Try a Free Trial
Country	Document Number	Estimated Expiration

Summary for MINOCIN

Pharmacology for MINOCIN

Medical Subject Heading (MeSH) Categories for MINOCIN

Synonyms for MINOCIN

For more information try a trial or see the plans and pricing